23andMe IPO

23andMe, founded in April 2006 by Linda Avey, Paul Cusenza, and Anne Wojcicki. The company has not officially endorsed a plan to participate in an IPO.

23andMe provides at-home, consumer genetic testing and was the first FDA-approved direct-to-consumer genetic sequencing supplier. More recently, 23andMe has leveraged its genetic database in pursuit of pharmaceutical drug development. The company has raised nearly $800 million in Venture Capital funding from investors including GlaxoSmithKline, Pegasus Tech Ventures, MicroVentures, G Squared, Sapphire Ventures, Sequoia Capital, SharesPost, Fidelity, GV, and Genetech. It has been widely reported that 23andMe last raised $300 million in July 2018 at a post-money valuation of $2.5 billion.

Register for Details

For more details on financing and valuation for 23andMe, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is 23andMe's ticker symbol?

ME

What is 23andMe's stock price?

2.28 as of 3/21/23

Who are 23andMe's major investors?

Fidelity Investments
Casdin Capital
Altimeter Capital
Sequoia Capital

23andMe Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
12/23/2020 Series F-1 $2.59B $XXX.XX $XXX.XX
9/12/2017 Series F $1.75B $XXX.XX $XXX.XX
6/8/2015 Series E $1.1B $XXX.XX $XXX.XX
12/10/2012 Series D $288.74MM $XXX.XX $XXX.XX
11/10/2010 Series C $184.5MM $XXX.XX $XXX.XX
12/23/2009 Series B $150.5MM $XXX.XX $XXX.XX
5/22/2007 Series A $48.5MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about 23andMe

Forge green plus iconForge green minus icon

What is 23andMe funding to date?

23andMe has raised $876.61MM with the following series:
$48.5MM for Series A, $150.5MM for Series B, $184.5MM for Series C, $288.74MM for Series D, $1.1B for Series E, $1.75B for Series F, $2.59B for Series F-1, $48.5MM for Series A, $150.5MM for Series B, $184.5MM for Series C, $288.74MM for Series D, $1.1B for Series E, $1.75B for Series F, $2.59B for Series F-1.
Forge green plus iconForge green minus icon

When was 23andMe founded?

23andMe was founded in 2006.